MATTHEW SWEENEY: Open Payments
NPI 1336160878 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 31 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $250 |
| Astellas Pharma US Inc | 5 | $144 |
| Novo Nordisk Inc | 9 | $137 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Lilly USA, LLC | 3 | $45 |
| Corcept Therapeutics | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Veozah, GIMOTI, AIRSUPRA, BREZTRI, Wegovy, JARDIANCE, Ozempic, Korlym.
Industry payments across AZ — which companies pay providers there.
